E. Doucet et al., IN-SITU HYBRIDIZATION EVIDENCE FOR THE SYNTHESIS OF 5-HT1B RECEPTOR IN SEROTONINERGIC NEURONS OF ANTERIOR RAPHE NUCLEI IN THE RAT-BRAIN, Synapse, 19(1), 1995, pp. 18-28
The regional distribution of the mRNA encoding the serotonin 5-HT1B re
ceptor was studied in the central nervous system of the rat by in situ
hybridization histochemistry and Northern blot analysis. A 180 base p
air probe, corresponding to a highly selective portion of the third in
tracellular loop of the rat 5-HT1B receptor, was used. In most regions
, a single 5 kb message was found by Northern blot analysis. However,
two additional bands (2.5 and 4 kb) were detected in the striatum. The
rank order of 5-HT1B mRNA abundance was striatum >> septum = ventral
tegmentum greater than or equal to colliculi = hypothalamus = hippocam
pus > brain stem greater than or equal to cerebellum greater than or e
qual to dorsal horn of the spinal cord > cerebral cortex greater than
or equal to ventral horn of the spinal cord > olfactory tubercle. This
distribution was confirmed by in situ hybridization, which further re
vealed that the 5-HT1B mRNA was present in dorsal root ganglia, the la
yer IV of the cerebral cortex, the Purkinje cell layer of the cerebell
um, the pyramidal neurons in the CA1 area of the hippocampus, and the
dorsal and median raphe nuclei. In situ hybridization was also perform
ed in nomifensine (10 mg/kg/i.p.)-pretreated rats whose serotoninergic
neurons were extensively and selectively lesioned by microinjection o
f 5,7-dihydrox-ytryptamine (8 mu g/1 mu l) directly into the anteroven
tral vicinity of anterior raphe nuclei 3 weeks before sacrifice. In le
sioned rats, 5-HT1B mRNA was present in the same areas and at the same
levels as in control rats, except in the dorsal and median raphe nucl
ei, where a marked decrease (-75%) in its local concentration was obse
rved. These data provide the first demonstration of the synthesis of 5
-HT1B receptor within serotoninergic neurons, as expected of their pre
synaptic autoreceptor function at the level of serotoninergic terminal
s. (C) 1995 Wiley-Liss, Inc.